Commercial insight into the pharma and biotech sector.
EvaluatePharma Alpha
EvaluatePharma Alpha is a cutting-edge, premium service quantifying market events and evaluating the impact on product, portfolio and company valuation.
Alpha is designed to increase your competitive advantage, positioning you ahead of key events with incisive analysis and innovative tools that quantify the potential impact on current valuation and future risk, including our interactive NPV (Net Present Value) Analyzer, Calendar of Events and daily comment and analysis from EP Vantage.
Contact Us for more information or to request a trial.
EvaluatePharma Classic
EvaluatePharma's original offering provides unique insight into past and future performance of the pharma and biotech sector with consensus forecast sales to 2014.
Our expert integration of financial and product data across historic and forecast timeframes (1986 to 2014) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, deals, license revenues and much more.
Contact Us for more information or to request a trial.
EvaluatePharma Registered User
Registered Users can access more free content including 2007 Product Sales analysis, 2007 Pharma Sales, 2007 Market Share and Global Rankings.
All free content can be searched by Company, Product, Generic Name, Therapeutic Category, Indication or you can create Peer Groups for company comparison.
Register Now to see a wider selection of insights and analysis available free of charge.
EvaluatePharma Free Content
We offer a selection of analysis and insights free of charge providing historic, top-level data for the world's leading pharma and biotech companies so visitors can experience EvaluatePharma in action.
Visit our home page and follow the links to view a selection of Company and Product Rankings and Deal reports, selected events from Calendar of Events plus News & Analysis, including EP Vantage.